Assessment of adherence to National Comprehensive Cancer Network guideline recommended anticoagulant therapy in the management of patients with cancer-associated venous thromboembolic disease
Maaen Journal for Medical Sciences · 22.09.2023 · 2 (3)
DOI: 10.55810/2789-9136.1025 ↗Kurz gefasst
Leitlinie in der Zeitschrift Maaen Journal for Medical Sciences, online erschienen am 22.09.2023. Verfasst von Ghufran Hassoun Naeemah und 1 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Background
Venous thromboembolism (VTE), a vascular disorder, is a serious and sometimes fatal problem, ranking as the second-deadliest complication for people with cancer. VTE includes pulmonary embolism, superficial vein thrombosis, deep vein thromboembolism, and internal vein thrombosis. It is important to note that cancer patients have almost nine times higher odds of dying from this illness.
Objective
The Najaf Cancer Center conducted a study to evaluate the effectiveness of oncologist strategies in the prevention and treatment of cancer-associated venous thromboembolism (VTE). The primary objective was to measure the adherence of VTE patients to anticoagulant therapy recommended by the NCCN guidelines.
Method
Conducting a one-of-a-kind investigation from the period of November 2022 to March 2023, the Middle Euphrates Cancer Center in Najaf Governorate, Iraq, is embarking on an extraordinary endeavor. Split into two distinct phases, an observation phase and an intervention prospective phase with a focus on an educational program, this groundbreaking study will involve a group of 100 patients. These patients, who have undergone treatment in hospitals and outpatient clinics and are over the age of 18, consist of both post-educational and pre-school individuals. Adopting the renowned NCCN guidelines and the Khorana risk score, this study aims to evaluate the risk score of patients with different types of cancer by implementing a well-established questionnaire...
Result
After completing the educational program, the prescription of anticoagulants for patients experienced a notable boost, increasing from a mere 6% to 13%. The assessment of adherence to the Cancer-associated VTE prophylaxis or treatment guideline categories revealed an interesting alteration in four of the categories following the program, while the other three categories showed no meaningful change. Nonetheless, when taking into account all seven categories, the overall adherence score saw a substantial improvement from 1.42 points prior to the program to 3.86 points afterwards (P
Zitieren
APA
Naeemah, G. H., & Ameen, A. A. H. (2023). Assessment of adherence to National Comprehensive Cancer Network guideline recommended anticoagulant therapy in the management of patients with cancer-associated venous thromboembolic disease. Maaen Journal for Medical Sciences, 2(3). https://doi.org/10.55810/2789-9136.1025
Vancouver
Naeemah GH, Ameen AAH. Assessment of adherence to National Comprehensive Cancer Network guideline recommended anticoagulant therapy in the management of patients with cancer-associated venous thromboembolic disease. Maaen Journal for Medical Sciences. 2023;2(3). doi:10.55810/2789-9136.1025
BibTeX
@article{Naeemah2023,
author = {Naeemah, Ghufran Hassoun and Ameen, Ayad Ali Hussein},
title = {Assessment of adherence to National Comprehensive Cancer Network guideline recommended anticoagulant therapy in the management of patients with cancer-associated venous thromboembolic disease},
journal = {Maaen Journal for Medical Sciences},
year = {2023},
volume = {2},
number = {3},
doi = {10.55810/2789-9136.1025}
}
EUVIMED